Celcuity To Participate in Upcoming Investor Conferences

What happened

Celcuity said CEO Brian Sullivan will present and hold one-on-one investor meetings at three healthcare conferences in November 2026: Guggenheim on November 10, Stifel on November 11, and Jefferies in London on November 18, with live webcasts and replays available.

Confirmed

Global impact / market context

Investor conferences give a small biotechnology company a direct channel to reach fund managers and specialists who decide whether to buy shares. Management can explain its plans and answer questions, which may help investors understand the company's first approved product and its pipeline of targeted cancer therapies.

Analyst inference

Celcuity is a commercial-stage biotechnology company whose value depends heavily on how doctors and insurers adopt its newly approved cancer drug. Conference appearances are routine but matter for thinly covered small companies, because they widen the pool of potential investors who hear management's story directly.

Analyst inference

What to watch

1. The Guggenheim fireside chat is scheduled for 3:00 p.m. EST on Tuesday, November 10, 2026, with a live webcast and a replay posted shortly after the event. Confirmed
2. Watch whether management uses the meetings to set out commercial launch plans and spending priorities for its approved therapy, since such disclosures would shape how investors judge future revenue and costs. Proposed
3. Track the Stifel and Jefferies sessions for management comments on demand for the approved product and on its remaining drug pipeline, because those details could change how investors value the shares. Analyst inference

Evidence

• globenewswire.com